Authors
Cnops, Lvan Griensven, J
Honko, AN
Bausch, DG
Sprecher, A
Hill, CE
Colebunders, R
Johnson, JC
Griffiths, A
Palacios, GF
Kraft, CS
Kobinger, G
Hewlett, A
Norwood, DA
Sabeti, P
Jahrling, PB
Formenty, P
Kuhn, JH
Ariën, KK
Issue Date
2016-10-01Submitted date
2016-10-03
Metadata
Show full item recordJournal
The Lancet. Infectious diseasesPublisher
ElsevierPubMed ID
27676345Language
enISSN
1474-4457ae974a485f413a2113503eed53cd6c53
10.1016/S1473-3099(16)30339-5
Scopus Count
Collections
Related articles
- Overlooking the importance of immunoassays.
- Authors: Dhillon RS, Kelly JD, Srikrishna D, Garry RF
- Issue date: 2016 Oct
- Using molecular similarity to highlight the challenges of routine immunoassay-based drug of abuse/toxicology screening in emergency medicine.
- Authors: Krasowski MD, Pizon AF, Siam MG, Giannoutsos S, Iyer M, Ekins S
- Issue date: 2009 Apr 28
- Authors' reply.
- Authors: Kahaly GJ, Diana T
- Issue date: 2016 Oct
- Colloidal nanomaterial-based immunoassay.
- Authors: Teste B, Descroix S
- Issue date: 2012 Jun
- Reply. Impact of assay design on test performance: lessons learned from 25-hydroxyvitamin D. Authors' response to the Letter to the Editor by Donnelly et al.
- Authors: Farrell CJ, Soldo J, McWhinney B, Bandodkar S, Herrmann M
- Issue date: 2015 Apr